Similar to ALK and ROS proto-oncogene 1 (ROS1) fusions, RET fusion is likely to be specific to lung adenocarcinoma, and mainly detected in young female and/or never/light-smoking patients which is similar to ROS1 fusion11–15. This evidence concerns the gene ROS1 and lung adenocarcinoma.